Completed PHASE2/PHASE3 INTERVENTIONAL NCT01409304

Effectiveness of Deep Transcranial Magnetic Stimulation in Depression

Effectiveness of Deep Transcranial Magnetic Stimulation for Treating Major Depression: a Pilot Study

Sponsor: Brainsway

Interventions Deep Transcranial Magnetic Stimulation (DTMS)

Updated 5 times since 2017 Last updated: Jan 16, 2013 Started: Oct 31, 2011 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Major Depressive Disorder and is currently completed. Brainsway leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brainsway
Douglas Mental Health University Institute

Data source: Douglas Mental Health University Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada